Shares of Porvair plc (LON:PRV – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 686.92 ($9.09) and traded as high as GBX 708 ($9.37). Porvair shares last traded at GBX 700 ($9.27), with a volume of 347,077 shares.
Wall Street Analysts Forecast Growth
Separately, Shore Capital restated a “hold” rating on shares of Porvair in a report on Tuesday.
Check Out Our Latest Report on Porvair
Porvair Stock Up 5.2 %
Porvair (LON:PRV – Get Free Report) last released its earnings results on Monday, February 10th. The company reported GBX 38.60 ($0.51) EPS for the quarter. Porvair had a net margin of 8.57% and a return on equity of 10.75%. Sell-side analysts anticipate that Porvair plc will post 39.0358613 earnings per share for the current fiscal year.
Porvair Increases Dividend
The firm also recently declared a dividend, which will be paid on Wednesday, June 4th. Shareholders of record on Thursday, May 1st will be paid a GBX 4.20 ($0.06) dividend. This represents a yield of 0.64%. The ex-dividend date is Thursday, May 1st. This is a positive change from Porvair’s previous dividend of $2.10. Porvair’s dividend payout ratio is presently 17.79%.
Insider Buying and Selling at Porvair
In other news, insider Ben Stocks sold 70,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of GBX 716 ($9.48), for a total transaction of £501,200 ($663,401.72). Insiders own 21.55% of the company’s stock.
Porvair Company Profile
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications.
Featured Stories
- Five stocks we like better than Porvair
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to Profit From Growth Investing
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Investing in the High PE Growth Stocks
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.